Can These 3 Healthcare Dividend Stocks Deliver Income Growth?

Key Points

S&P 500 components Pfizer Medtronic and Gilead are undervalued dividend stocks from the healthcare sector.
All three have a history of increasing their dividends.
The healthcare sector historically does well during bouts of economic sluggishness, which bodes well for income investors.
Five stocks we like better than Gilead Sciences.

Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Gilead Sciences Right Now?

Before you consider Gilead Sciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gilead Sciences wasn't on the list.

While Gilead Sciences currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

About The Author

Kate Stalter

Contributing Author

Retirement, Asset Allocation, and Tax Strategies

Learn More

Companies Mentioned in This Article

Company	MarketRank™	Current Price	Price Change	Dividend Yield	P/E Ratio	Consensus Rating	Consensus Price Target
Gilead Sciences (GILD)	4.9737 of 5 stars	$97.41	-0.8%	3.24%	263.26	Moderate Buy	$110.55
Medtronic (MDT)	4.4958 of 5 stars	$83.64	+0.0%	3.35%	25.42	Hold	$96.14
Pfizer (PFE)	4.9992 of 5 stars	$22.56	+0.1%	7.62%	16.00	Moderate Buy	$29.17
Eli Lilly and Company (LLY)	4.991 of 5 stars	$758.88	+1.0%	0.79%	64.81	Moderate Buy	$1,002.80

Compare These Stocks Add These Stocks to My Watchlist

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Can These 3 Healthcare Dividend Stocks Deliver Income Growth?

Key Points

Upgrade Now

Should You Invest $1,000 in Gilead Sciences Right Now?

Kate Stalter

Contributing Author

Companies Mentioned in This Article

Featured Articles and Offers

Recent Videos

Stock Lists

Investing Tools

Search Headlines

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Can These 3 Healthcare Dividend Stocks Deliver Income Growth?

Key Points

Upgrade Now

Should You Invest $1,000 in Gilead Sciences Right Now?

Kate Stalter

Contributing Author

Companies Mentioned in This Article

Featured Articles and Offers

Recent Videos

Stock Lists

Investing Tools

Search Headlines

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools